DENVER & BANNOCKBURN, Ill. - Palantir Technologies Inc . (NYSE: NYSE:PLTR) and Option Care Health Inc. (NASDAQ: NASDAQ:OPCH) have announced a multi-year partnership aimed at deploying Palantir's Artificial Intelligence Platform (AIP) across various operational facets of Option Care Health to improve patient outcomes and operational efficiency.
The collaboration intends to integrate AIP into processes such as nurse scheduling, patient onboarding, and supply chain management. Palantir's AIP is designed to unify disparate data sources and systems, providing a cohesive operating picture to enhance decision-making capabilities.
Option Care Health plans to leverage the platform to increase the number of patient visits, reduce administrative tasks, and maintain optimal levels of medical supplies, thus preventing both shortages and overstocking.
John Rademacher, President & CEO of Option Care Health, expressed enthusiasm about the partnership, highlighting the potential to accelerate innovation and build upon best practices in AI and Machine Learning. He emphasized the importance of establishing a strong foundation for AI applications to benefit stakeholders.
Palantir, known for its collaborations with significant global organizations, has expanded its healthcare operations, working with institutions like the National Institutes of Health and the U.K.'s National Health Service. Alex Karp, CEO of Palantir Technologies, remarked on the significance of Option Care Health's role in adopting AI in healthcare and expressed pride in supporting their efforts to enhance patient services nationwide.
Option Care Health is recognized as the largest independent national provider of home and alternate site infusion services in the United States. The company employs over 7,500 team members, including more than 4,500 clinicians, and operates in all 50 states.
The information for this article is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.